Improving intraperitoneal adenovirus virotherapy for ovarian cancer

<p>The use of intraperitoneal (i.p.) adenovirus virotherapy of ovarian cancer is currently limited by insufficient efficacy and high toxicity. Both factors are associated with adenovirus serotype 5 (Ad5) in this setting and may be serotype-specific. Low levels of uptake receptors (CAR and αV...

Cijeli opis

Bibliografski detalji
Glavni autor: Thoma, CMM
Daljnji autori: Morrison, J
Format: Disertacija
Jezik:English
Izdano: 2011
Teme:

Slični predmeti